Effect of beetroot or beetroot plus vitamin C supplementation on cardiovascular function in patients with coronary

Leila Sadat Bahrami1,2, Mohsen Mohebaty3, Seyyed Mostafa Arabi1,4

  • 1Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

BMJ Open
|June 16, 2022
PubMed

Insights

This study investigates beetroot and vitamin C supplementation for coronary artery disease (CAD) patients. It aims to improve cardiovascular health markers and function in individuals with atherosclerosis.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Clinical Trials

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Atherosclerosis, the underlying cause of CAD, necessitates effective interventions.
  • Current treatments for CAD often have limitations, driving research into novel therapeutic approaches.

Purpose of the Study:

  • To evaluate the impact of beetroot and beetroot with vitamin C supplementation on cardiovascular health in CAD patients.
  • To assess changes in key cardiovascular function and inflammatory markers.
  • To compare the efficacy of beetroot alone versus combined beetroot and vitamin C therapy.

Main Methods:

  • A 4-week, randomized, double-blind, placebo-controlled trial involving 90 CAD patients.
  • Participants were assigned to receive beetroot capsules, beetroot plus vitamin C capsules, or placebo.
  • Measurements included pulse wave velocity, Augmentation Index, VO2 max, blood pressure, inflammatory markers (IL-6, hs-CRP), and lipid profiles.

Main Results:

  • The study is designed to measure significant changes in cardiovascular parameters.
  • Potential improvements in endothelial function and exercise capacity are anticipated.
  • The impact on inflammatory markers and lipid profiles will be analyzed.

Conclusions:

  • Findings will elucidate the potential of beetroot and vitamin C as adjunctive therapies for CAD.
  • Results may inform clinical practice regarding nutritional interventions for cardiovascular health.
  • Further research may be warranted based on the observed effects.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
29
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
330
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32